About 3SBio (NASDAQ:SSRX)
3SBio Inc. is a biotechnology company in the People's Republic of China with research and development, manufacturing, and marketing capabilities focusing on bio-pharmaceutical products. The Company recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin; and an in-licensed product, Iron Sucrose Supplement. The Company focuses on its research and development efforts on both novel and validated protein-based therapeutics for the treatment of diseases in the areas of nephrology, oncology, supportive cancer care, inflammation and infectious diseases, and other selected areas. In May 2013, the Company merged with Decade Sunshine Limited and Decade Sunshine Merger Sub.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:SSRX
CUSIPN/A
Phone+86-24-25811820
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
3SBio (NASDAQ:SSRX) Frequently Asked Questions
What is 3SBio's stock symbol?
3SBio trades on the NASDAQ under the ticker symbol "SSRX."
How were 3SBio's earnings last quarter?
3SBio Inc (NASDAQ:SSRX) released its quarterly earnings results on Monday, March, 18th. The biotechnology company reported $0.12 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.14 by $0.02. The biotechnology company earned $26.30 million during the quarter, compared to analysts' expectations of $25.63 million. View 3SBio's Earnings History.
Who are 3SBio's key executives?
3SBio's management team includes the folowing people:
- Jing Lou, Executive Chairman of the Board, Chief Executive Officer (Age 54)
- Bo Tan, Chief Financial Officer, Executive Vice President, Executive Director (Age 44)
- Fei You, Director - Finance (Age 38)
- Weihonghas Xiao, Chief Operating Officer (Age 48)
- Dongmei Su, Senior Vice President, Executive Director (Age 46)
- Zhenping Zhu MD. Ph.D., Chief Scientific Officer, President - Research & Development (Age 52)
- Bin Huang, Vice President, Executive Director (Age 56)
- Xin Ma, Vice President - Human Resources (Age 51)
- Yongfu Chen, Vice President (Age 60)
- Kevin Liu, Vice President (Age 47)
Has 3SBio been receiving favorable news coverage?
News headlines about SSRX stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. 3SBio earned a daily sentiment score of 0.14 on Accern's scale. They also gave media headlines about the biotechnology company an impact score of 45.28 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
How do I buy shares of 3SBio?
Shares of SSRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is 3SBio's stock price today?
One share of SSRX stock can currently be purchased for approximately $16.59.
How big of a company is 3SBio?
3SBio has a market capitalization of $366.10 million.
How can I contact 3SBio?
3SBio's mailing address is No. 3 A1, Road 10 Shenyang Economy & Technology Development Zone, SHENYANG, LIA 110027, China. The biotechnology company can be reached via phone at +86-24-25811820.
MarketBeat Community Rating for 3SBio (SSRX)
MarketBeat's community ratings are surveys of what our community members think about 3SBio and other stocks. Vote "Outperform" if you believe SSRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
3SBio (NASDAQ:SSRX) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | N/A | N/A | Buy | Buy |
| Consensus Rating Score: | N/A | N/A | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | N/A | N/A | N/A | N/A |
| Price Target Upside: | N/A | N/A | N/A | N/A |
3SBio (NASDAQ:SSRX) Consensus Price Target History
3SBio (NASDAQ:SSRX) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 3/20/2017 | Goldman Sachs | Upgrade | Neutral -> Buy | | Low |  |
(Data available from 4/24/2016 forward)
3SBio (NASDAQ:SSRX) Earnings History and Estimates Chart
3SBio (NASDAQ SSRX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/18/2013 | Q4 2012 | $0.14 | $0.12 | $25.63 million | $26.30 million | View | Listen | |
| 11/12/2012 | Q312 | $0.29 | $0.15 | $28.18 million | $28.70 million | View | N/A | |
| 8/14/2012 | Q2 2012 | $0.24 | $0.29 | | | View | N/A | |
| 5/13/2012 | Q1 2012 | $0.20 | $0.23 | | | View | N/A | |
| 3/8/2012 | Q4 2011 | $0.14 | $0.16 | | | View | N/A | |
| 11/10/2011 | Q3 2011 | $0.23 | $0.23 | | | View | N/A | |
| 8/15/2011 | Q2 2011 | $0.20 | $0.21 | | | View | N/A | |
| 5/11/2011 | Q1 2011 | $0.18 | $0.15 | | | View | N/A | |
| 3/15/2011 | Q4 2010 | $0.06 | $0.11 | | | View | N/A | |
| 11/15/2010 | Q3 2010 | $0.18 | $0.15 | | | View | N/A | |
| 8/17/2010 | Q2 2010 | $0.17 | $0.17 | | | View | N/A | |
| 5/16/2010 | Q1 2010 | $0.16 | $0.18 | | | View | N/A | |
| 2/11/2010 | Q4 2009 | $0.07 | $0.10 | | | View | N/A | |
| 11/12/2009 | Q3 2009 | $0.15 | $0.18 | | | View | N/A | |
| 8/11/2009 | Q2 2009 | $0.13 | $0.18 | | | View | N/A | |
| 5/19/2009 | Q1 2009 | $0.12 | $0.14 | | | View | N/A | |
| 3/11/2009 | Q4 2008 | $0.11 | $0.08 | | | View | N/A | |
| 11/10/2008 | Q3 2008 | $0.14 | $0.14 | | | View | N/A | |
| 8/12/2008 | Q2 2008 | $0.13 | $0.13 | | | View | N/A | |
| 5/14/2008 | Q1 2008 | $0.12 | $0.13 | | | View | N/A | |
| 2/20/2008 | Q4 2007 | $0.13 | $0.11 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
3SBio (NASDAQ:SSRX) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
3SBio (NASDAQ SSRX) Insider Trading and Institutional Ownership History
3SBio (NASDAQ SSRX) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
3SBio (NASDAQ SSRX) News Headlines
| Source: |
|
3SBio (NASDAQ:SSRX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
3SBio (NASDAQ:SSRX) Income Statement, Balance Sheet and Cash Flow Statement
3SBio (NASDAQ SSRX) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
